GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹2,194 Cr | ₹991 Cr | ₹4,348 Cr | ₹3,670 Cr | ₹4,687 Cr |
What is the latest Total Debt ratio of GLENMARK PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹2,194 Cr |
| Mar2024 | ₹991 Cr |
| Mar2023 | ₹4,348 Cr |
| Mar2022 | ₹3,670 Cr |
| Mar2021 | ₹4,687 Cr |
How is Total Debt of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,194 Cr | 121.50 | |
| Mar2024 | ₹991 Cr | -77.22 | |
| Mar2023 | ₹4,348 Cr | 18.46 | |
| Mar2022 | ₹3,670 Cr | -21.70 | |
| Mar2021 | ₹4,687 Cr | - | |
Compare Total Debt of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,831.4 Cr | -0.1% | 1.6% | 5.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.1% |
1.6% |
5.8% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses